AIMS: Effectiveness of nicotine replacement therapy (NRT) for smoking cessation has not been evaluated in low income countries, such as Syria, where it is expensive and not widely available. We evaluated whether nicotine patch boosts smoking cessation rates when used in conjunction with behavioral support in primary care clinics in Aleppo, Syria. DESIGN: Two arm, parallel group, randomized, placebo controlled, double-blinded multi-site trial. SETTING:Four primary care clinics in Aleppo, Syria. PARTICIPANTS: Two hundred and sixty-nine adult primary care patients receivedbehavioral cessation counseling from a trained primary care physician and were randomized to receive six weeks of treatment with nicotine versus placebo patch. MEASUREMENTS: Primary end-points were prolonged abstinence (no smoking after a 2-week grace period) at end of treatment, and 6 and 12 months post-quit day, assessed by self-report and exhaled carbon monoxide levels of <10 p.p.m. FINDINGS: Treatment adherence was excellent and nicotine patch produced expected reductions in urges to smoke and withdrawal symptoms, but no treatment effect was observed. The proportion of patients in the nicotine and placebo groups with prolonged abstinence was 21.6% and 20.0%, respectively, at end of treatment, 13.4% and 14.1% at 6 months, and 12.7% and 11.9% at 12 months. CONCLUSIONS:Nicotine patches may not be effective in helping smokers in low-income countries to stop when given as an adjunct to behavioural support.
RCT Entities:
AIMS: Effectiveness of nicotine replacement therapy (NRT) for smoking cessation has not been evaluated in low income countries, such as Syria, where it is expensive and not widely available. We evaluated whether nicotine patch boosts smoking cessation rates when used in conjunction with behavioral support in primary care clinics in Aleppo, Syria. DESIGN: Two arm, parallel group, randomized, placebo controlled, double-blinded multi-site trial. SETTING: Four primary care clinics in Aleppo, Syria. PARTICIPANTS: Two hundred and sixty-nine adult primary care patients received behavioral cessation counseling from a trained primary care physician and were randomized to receive six weeks of treatment with nicotine versus placebo patch. MEASUREMENTS: Primary end-points were prolonged abstinence (no smoking after a 2-week grace period) at end of treatment, and 6 and 12 months post-quit day, assessed by self-report and exhaled carbon monoxide levels of <10 p.p.m. FINDINGS: Treatment adherence was excellent and nicotine patch produced expected reductions in urges to smoke and withdrawal symptoms, but no treatment effect was observed. The proportion of patients in the nicotine and placebo groups with prolonged abstinence was 21.6% and 20.0%, respectively, at end of treatment, 13.4% and 14.1% at 6 months, and 12.7% and 11.9% at 12 months. CONCLUSIONS:Nicotine patches may not be effective in helping smokers in low-income countries to stop when given as an adjunct to behavioural support.
Authors: E D Levin; E C Westman; R M Stein; E Carnahan; M Sanchez; S Herman; F M Behm; J E Rose Journal: J Clin Psychopharmacol Date: 1994-02 Impact factor: 3.153
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: Ziyad Ben Taleb; Kenneth D Ward; Taghrid Asfar; Rana Jaber; Rehab Auf; Wasim Maziak Journal: Int J Public Health Date: 2016-04-15 Impact factor: 3.380
Authors: Joshua L Karelitz; Erin A McClure; Caitlin Wolford-Clevenger; Lauren R Pacek; Karen L Cropsey Journal: Drug Alcohol Depend Date: 2021-02-03 Impact factor: 4.492
Authors: Robert West; Martin Raw; Ann McNeill; Lindsay Stead; Paul Aveyard; John Bitton; John Stapleton; Hayden McRobbie; Subhash Pokhrel; Adam Lester-George; Ron Borland Journal: Addiction Date: 2015-09 Impact factor: 6.526
Authors: Philip H Smith; Andrea H Weinberger; Ju Zhang; Erin Emme; Carolyn M Mazure; Sherry A McKee Journal: Nicotine Tob Res Date: 2017-03-01 Impact factor: 4.244